tirzepatide and long covid Can a weight loss diabetes drug treat COVID? – San Diego Union-Tribune Scripps Research has launched a

Is microdosing Zepbound (tirzepatide), a GLP1/GIP receptor agonist, appropriate for treating longCOVID (postviral syndrome)?

In all three studies, adults with obesity or overweight with at least one weight-related comorbidity were randomly assigned to once-weekly subcutaneous tirzepatide or placebo for 72 weeks

Among 36 participants with CGM data available, time in range with glucose between 70 mg/dL and 180 mg/dL increased from 55.1% at baseline to 62.3% at 6 months ( P = .022)

Full text: Gold, J

Heres a price comparison of Mounjaro 2.5 mg/0.5 mL pen at different pharmacies, according to GoodRx

You will have to pay for it every month forever